m625 is not a clinical decision tool · not a publisher · not an expert authority · not a simulator. It is a cross-domain Roll-formalized evidence atlas with public audit + attack surface.
persona: patient advocate · domain: cancer · tier: 1
ferry target:m511 · fixture id: DEMO-016
self-audit grade:A
i_demo_016 · patient advocate × cancer · how to read evidence-language without the marketing
Why a cancer-survivor advocate would come to evidence.x1000.ai
A cancer survivor (or family member, or patient-advocacy group volunteer) reads a constant stream of oncology marketing dressed as evidence. Pain points:
miracle / breakthrough / 100% effective framing is everywhere, in both lay press and sponsor decks;
distinguishing a real Tier-1 evidence claim from sponsor-imply marketing is hard;
m625 does not provide medical advice. **m625 shows what a real Roll-formalized cancer evidence claim looks like (anchored on m610's 3 base cooked cases) and how to tell it apart from marketing language**.
This is not patient-facing medical advice. This is not a treatment plan.
The Roll-formalized object: the contrast between cooked evidence and marketing
3 base cooked cases · each ≥ B grade machine audit
revolutionary-breakthrough
Honest verdict 4-section (done / open / weakness / counter)
100% effective miracle
The contrast is the lesson, not the cases themselves.
How a cancer-survivor advocate should read this (≤ 5 minutes)
Find the K4.1 declaration. A genuine Roll-formalized cancer evidence claim has a 3-bit K4.1 declaration (per m604 V2.6 sovereign reference · Kernel §3.4). If a sponsor's pitch deck or community resource cannot point to one, the framework says: this is below Tier-1.
Find the falsifying prediction. Real evidence carries a statement of what would prove it wrong. "Here is what would prove this wrong: N-doubled re-cook fails" is a falsifying prediction. This always works is not.
Find the source citation chain. Numbers tied to NCT / PubMed / DOI IDs are anchorable. Numbers with no source are training_data_recall at best, fabrication at worst (W6.1).
Find the honest verdict section. A real demo says what's open, what's weak, and what would defeat its own claim. Marketing says only what works.
Five marketing patterns m625 has cataloged as attack-surface fixtures
ID
Pattern
What to watch for
AS-001
cure cancer smuggle
direct vocabulary use
AS-005
simulate patient trajectory
tool-as-engine over-claim
AS-006
personalized digital twin
per-patient model promise
AS-010
revolutionary-breakthrough + FDA approved + act now + limited time
full marketing stack
AS-029
personalized treatment via unique digital twin learning in real time
adaptive-learning over-claim
m625's audit catches all of these in the audit pipeline. A community resource that does not catch them is structurally weaker than one that does.
Cross-domain reading aid (per W6.3)
If a survivor advocate also lives with chronic pain or CKD or autism (cross-comorbidity), the K4.1 bit pattern of each condition's cooked Roll claim differs:
cancer EGFR-NSCLC TKI · (0, 1, 1)
chronic pain Tu 2020 · (1, 1, 0)
CKD progression · (1, 1, 0)
These are **structurally different claims**. A community resource that conflates them is making a W6.3 cross-domain conflation error. transferability_pct: not directly transferable at the substantive level.
What this demo will not say (anti-drift)
❌ It does not promise reversal, eradication, or rescue for cancer survivors (cure / reverse lexicon).
❌ It does not assign per-person trajectory for any survivor (NCNU P_3).
❌ It does not affirm or vouch for any oncology clinic, hospital, or sponsor.
❌ It does not name specific drugs or supplements as recommended.
❌ It does not use miracle / breakthrough / state-of-the-art lexicon.
Falsifying prediction
The "real evidence has K4.1 + falsifying prediction + audited source chain + honest verdict" framing is falsified by:
a published Tier-1 oncology evidence paper that demonstrably lacks all four components and yet is consensus-grade; OR
a sponsor-deck that meets all four components and yet is consensus-rejected as marketing.
待办: plain-language Chinese variant (v1.0+); per-cancer-subtype reading aids (breast vs lung vs lymphoma) — open work.
漏洞: contrast table is illustrative · the boundary between "marketing" and "Tier-2 evidence not yet at Tier-1 standard" is not perfectly bright. Some claims that fail one of the four checks may still be honest exploratory work; readers should not weaponize this reading aid against legitimate cautious claims.
反驳预案:
- *"This dismisses too much hopeful framing."* — That is the point. Hope is not evidence. m625's role is to teach the language; community decisions about hope are separate.
- *"My doctor uses the `cure` word and they're trustworthy."* — Possibly. Specific clinicians may use shorthand that the framework forbids in writing. The framework is about *publishable language*, not bedside conversation.